Skip to main content
OpenTrials

Clinical trial condition

Skin and Connective Tissue Diseases

Explore clinical trials studying Skin and Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

28,259 public trials 4,410 recruiting studies
Refine in advanced search Browse all conditions

Skin and Connective Tissue Diseases trial results

Recruiting

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

NCT05412225

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) Commack, New York, United States
View Trial Details
Recruiting

Adult and Juvenile Myositis

NCT00017914

Conditions
Connective Tissue Diseases, Dermatomyositis, Inclusion Body Myositis, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NIEHS Clinical Research Unit (CRU) Research Triangle Park, North Carolina, United States
  • Texas Scottish Rite Hospital Dallas, Texas, United States
View Trial Details
Recruiting

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

NCT05523947

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +12 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States
  • Southern Oncology Clinical Research Unit Adelaide, Australia
  • Austin Health Melbourne, Australia
View all 19 locations
View Trial Details
Recruiting

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07229313

Conditions
Adnexal Diseases, Advance Solid Tumors, Breast Diseases, +59 more
Locations
  • Kivu Trial Site Santa Monica, California, United States
  • Kivu Trial Site Camperdown, New South Wales, Australia
  • Kivu Trial Site Sydney, New South Wales, Australia
  • Kivu Trial Site Brisbane, Queensland, Australia
View Trial Details
Recruiting

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

NCT07068074

Conditions
Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
View all 181 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

NCT06655155

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • Arizona Arthritis and Rheumatology Associates Phoenix, Arizona, United States
  • UCLA Ronald Reagan University of California Los Angeles Medical Center Los Angeles, California, United States
  • IRIS Research and Development LLC Plantation, Florida, United States
  • University of Illinois Health Outpatient Care Center Chicago, Illinois, United States
View all 79 locations
View Trial Details
Recruiting

ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

NCT07783542

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Oruka Therapeutics Investigative Site Chapel Hill, North Carolina, United States
  • Oruka Therapeutics Investigative Site Dallas, Texas, United States
  • Oruka Therapeutics Investigative Site Birmingham, Alabama, United States
  • Oruka Therapeutics Investigative Site Fountain Valley, California, United States
View all 15 locations
View Trial Details

Related conditions